Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial to Investigate Clinical Efficacy of Autologous Synovial Fluid Mesenchymal Stem Cell-Derived Exosome Application in Patients With Degenerative Meniscal Injury

NCT05261360 is registered in ClinicalTrials.gov with Eskisehir Osmangazi University as lead sponsor.

NCT NCT05261360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05261360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial to Investigate Clinical Efficacy of Autologous Synovial Fluid Mesenchymal Stem Cell-Derived Exosome Application in Patients With Degenerative Meniscal Injury
Lead sponsor
Eskisehir Osmangazi University
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2022
Completion date
March 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthralgia, knee injuries, knee pain swelling, knee; injury, meniscus (lateral) (medial), meniscus injury, tibial, meniscus lesion, meniscus tear, meniscus; degeneration, meniscus; laceration